FDA UNTITLED_LETTER - Barclay, Luke, & Pillai Specialty Pharmacy, PLLC - December 09, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This UNTITLED LETTER record concerns Barclay, Luke, & Pillai Specialty Pharmacy, PLLC, with an inspection on December 9, 2022, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Barclay, Luke, & Pillai Specialty Pharmacy, PLLC
Inspection Date: December 9, 2022
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Rumany C. Penn (Compliance Officer)
Sean M. Barclay
Steven E. Porter (Program Division Director)

Open in Dashboard

ID · fde231f5-ecde-4b89-b54a-8e12069df1cd

Violation Codes8

21 U.S.C. 331(k)21 CFR 211.165(a)21 U.S.C. 352(f)(1)21 CFR 211.84(d)(1)FD&C Act 501(a)(2)(A)FD&C Act 502(f)(1)21 U.S.C. 355(a)21 U.S.C. 353a

Full citation text and observation details available on the Dashboard.